TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Moberg Pharma AB
Closing information (x1000 EUR)
| Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Turnover |
0
|
19
|
0 |
| Financial expenses |
23
|
6
|
23 |
| Earnings before taxes |
-2,291
|
-1,753
|
-1,953 |
| EBITDA |
-2,286
|
-1,586
|
-1,677 |
| Total assets |
57,204
|
50,720
|
44,089 |
| Current assets |
6,263
|
11,481
|
10,233 |
| Current liabilities |
1,851
|
2,407
|
1,519 |
| Equity capital |
55,040
|
47,948
|
42,442 |
| - share capital |
2,520
|
883
|
431 |
| Employees (average) |
10
|
8
|
8 |
Financial ratios
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Solvency |
96.2%
|
94.5%
|
96.3% |
| Turnover per employee |
0
|
2
|
0 |
| Profit as a percentage of turnover | -9226.3% | ||
| Return on assets (ROA) |
-4.0%
|
-3.4%
|
-4.4% |
| Current ratio |
338.4%
|
477.0%
|
673.7% |
| Return on equity (ROE) |
-4.2%
|
-3.7%
|
-4.6% |
| Change turnover |
-19
|
19
|
-4,937 |
| Change turnover % | -100% | -100% | |
| Chg. No. of employees |
2
|
0
|
-3 |
| Chg. No. of employees % |
25%
|
0%
|
-27% |
Total value of public sale
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.